Literature DB >> 2748515

Experimental animal models for studying antimicrobial pharmacokinetics in otitis media.

D M Canafax1, N Nonomura, G R Erdmann, C T Le, S K Juhn, G S Giebink.   

Abstract

Antimicrobial treatment of otitis media, especially drug dosing considerations, is largely empiric, with few reported pharmacologic studies of drug distribution into the middle ear. A chinchilla animal model of serous and purulent otitis media has been used for some time to investigate mechanisms of disease pathogenesis. This model was adapted to investigate the penetration of amoxicillin, trimethoprim, and sulfamethoxazole into middle ear effusion. Purulent otitis media was produced by direct middle ear inoculation with type 7F Streptococcus pneumoniae. Serous otitis media was produced by eustachian tube obstruction using silastic sponge or Coeflex cement, but the Coeflex caused an undesirable local inflammatory response. The three antibiotics were administered to chinchillas with serous and purulent middle ear effusion. Plasma and ear fluid drug concentrations were measured by liquid chromatography and demonstrated the value of this model in assessing antibiotic penetration.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2748515     DOI: 10.1023/a:1015938205892

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  4 in total

1.  The contribution of pneumococcal cell wall to the pathogenesis of experimental otitis media.

Authors:  M L Ripley-Petzoldt; G S Giebink; S K Juhn; D Aeppli; A Tomasz; E Tuomanen
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

2.  The pathogenesis of pneumococcal otitis media in chinchillas and the efficacy of vaccination in prophylaxis.

Authors:  G S Giebink
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr

3.  Different virulence of influenza A virus strains and susceptibility to pneumococcal otitis media in chinchillas.

Authors:  G S Giebink; P F Wright
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

4.  Tympanometric configurations and middle ear findings in experimental otitis media.

Authors:  G S Giebink; K A Heller; E R Harford
Journal:  Ann Otol Rhinol Laryngol       Date:  1982 Jan-Feb       Impact factor: 1.547

  4 in total
  15 in total

1.  The chinchilla microdialysis model for the study of antibiotic distribution to middle ear fluid.

Authors:  Belinda W Y Cheung; Wei Liu; Ping Ji; Linda L Cartier; Zhihong Li; Nael Mostafa; Ronald J Sawchuk
Journal:  AAPS J       Date:  2006-02-03       Impact factor: 4.009

2.  Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies.

Authors:  P D Lister; A Pong; S A Chartrand; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

3.  An experimental model for measuring middle ear antimicrobial drug penetration in otitis media.

Authors:  G H Jossart; G R Erdmann; D G Levitt; P Kucera; C T Le; S K Juhn; G S Giebink; D M Canafax
Journal:  Pharm Res       Date:  1990-12       Impact factor: 4.200

4.  Middle ear fluid cytokine and inflammatory cell kinetics in the chinchilla otitis media model.

Authors:  K Sato; C L Liebeler; M K Quartey; C T Le; G S Giebink
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

5.  Penicillin treatment accelerates middle ear inflammation in experimental pneumococcal otitis media.

Authors:  M Kawana; C Kawana; G S Giebink
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

Review 6.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

7.  Oxidative metabolic products released from polymorphonuclear leukocytes in middle ear fluid during experimental pneumococcal otitis media.

Authors:  M Kawana; C Kawana; T Yokoo; P G Quie; G S Giebink
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

8.  Estimating amoxicillin influx/efflux in chinchilla middle ear fluid and simultaneous measurement of antibacterial effect.

Authors:  Yue Huang; Zheng Yang; Linda Cartier; Belinda Cheung; Ronald J Sawchuk
Journal:  Antimicrob Agents Chemother       Date:  2007-10-08       Impact factor: 5.191

9.  Effect of Streptococcus pneumoniae and influenza A virus on middle ear antimicrobial pharmacokinetics in experimental otitis media.

Authors:  G H Jossart; D M Canafax; G R Erdmann; M J Lovdahl; H Q Russlie; S K Juhn; G S Giebink
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

10.  Comparison of two otitis media models for the study of middle ear antimicrobial pharmacokinetics.

Authors:  D M Canafax; H Russlie; M J Lovdahl; G R Erdmann; C T Le; G S Giebink
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.